This past week, the U.S. Drug Enforcement Agency and the U.S. Department of Health and Human Services said it would temporarily extend telemedicine flexibilities for the prescription of certain controlled medications granted under the COVID-19 Public…
Continue Reading
The DEA and SAMHSA have extended telehealth prescribing flexibilities for controlled substances through November 11, 2024, following a temporary rule. The move comes after several healthcare organizations, including the AHA, requested continued telehealth prescribing…
Continue Reading
What You Should Know:Today, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a…
Continue Reading
By Mark Melchionna
May 08, 2023 – Led by Sen. Edward J. Markey (D-Mass.), a group of US senators have urged the Drug Enforcement Agency (DEA) to permanently establish telehealth flexibilities in prescribing buprenorphine for opioid…
Continue Reading
The U.S. Drug Enforcement Agency (DEA) will extend telemedicine flexibilities around the prescription of certain controlled medications as it considers stakeholder feedback on proposed rules for post-COVID remote prescribing guardrails. The DEA received over…
Continue Reading
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s…
Continue Reading
With the COVID-19 Public Health Emergency set to expire on May 11, the U.S. Drug Enforcement Agency says it will temporarily extend telemedicine flexibilities around prescription of certain controlled medications as it sifts through…
Continue Reading
After the Drug Enforcement Administration (DEA) announced Wednesday that it is temporarily extending Covid-19 flexibilities for the prescribing of controlled substances via telemedicine, several telehealth advocates came out in support of the decision.
These flexibilities…
The unprecedented expansion of telehealth and mental health care during the pandemic was a monumental shift for behavioral health care in more ways than one.
The flexibilities for behavioral health visits that resulted from the…
In late February, the Drug Enforcement Administration announced a set of proposed rules that would roll back some of the flexibilities allowed during the pandemic for the prescribing of controlled substances via telemedicine. The…
Continue Reading
